InterCure Stock

InterCure OCF Margin

The Operating Cash Flow Margin of InterCure (INCR.TA) as of Jun 26, 2026 is -0.28.In the previous year, Operating Cash Flow Margin was -0.15 — a change of 85.77% (lower).

OCF Margin

-0.28

YoY

85.77%

Last updated:

Operating Cash Flow Margin of InterCure is 2026 -0.28 . Operating Cash Flow Margin of InterCure was 2025 -0.15 . It decreases by 85.77% lower compared to the previous year.
Access this data via the Eulerpool API

InterCure Stock analysis

What does InterCure do? InterCure Ltd. is a global company in the medical technology industry that focuses on the development, production, and distribution of innovative solutions for the diagnosis and treatment of chronic diseases. The company was founded in Israel in 2000 and is headquartered in Lod. InterCure is one of the most popular companies on Eulerpool.

Frequently Asked Questions about InterCure stock

Operating Cash Flow Margin of InterCure amounted to -0.15 -0.28

Access this data via the Eulerpool API

Margins — InterCure

All Key Metrics — InterCure